Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Cambrex-Inspections

More Like This

PR Newswire associated0

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

PR Newswire associated0

Cambrex Advances US and European Expansions

PR Newswire associated0

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

PR Newswire associated0

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

PR Newswire associated0

Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility